Genitourinary Medical Oncology

Faculty and staff of the Department of Genitourinary Medical Oncology are dedicated to the treatment, research, and prevention of genitourinary cancers of the prostate, bladder, kidney, testes, and penis.


The mission of the Department of Genitourinary Medical Oncology is to reduce the morbidity and mortality of genitourinary cancers for the benefit of our patients and for future generations.


Our clinical care is based on research into the biology of genitourinary tumors. With a clearer understanding of the biologic behavior of genes, molecules, and cells that are responsible for the formation and growth of these tumors, we have been able to develop treatments tailored to the individual patient. The Department of Genitourinary Medical Oncology is at the leading edge of research to identify important biologic markers to help us determine which patients are at greatest risk of advanced disease and metastasis.

These powerful tools combined with the use of innovative therapeutic agents will increase survival and promote a better quality of life for patients with genitourinary cancers.

The Department has created an interactive environment in which ideas are freely exchanged among basic science, translational, and clinical investigators in the Genitourinary Center, the David H. Koch Center, throughout the institution, and around the world.


Critical to the success of the Department of Genitourinary Medical Oncology is the education of young clinicians and investigators who will build on the foundation of our work and ensure continued meaningful contributions to the treatment, prevention, and research of genitourinary cancers.